Literature DB >> 26707496

Update of Inpatient Treatment for Refractory Chronic Daily Headache.

Tzu-Hsien Lai1,2, Shuu-Jiun Wang3,4.   

Abstract

Chronic daily headache (CDH) is a group of headache disorders, in which headaches occur daily or near-daily (>15 days per month) and last for more than 3 months. Important CDH subtypes include chronic migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. Other headaches with shorter durations (<4 h/day) are usually not included in CDH. Common comorbidities of CDH are medication overuse headache and various psychiatric disorders, such as depression and anxiety. Indications of inpatient treatment for CDH patients include poor responses to outpatient management, need for detoxification for overuse of specific medications (particularly opioids and barbiturates), and severe psychiatric comorbidities. Inpatient treatment usually involves stopping acute pain, preventing future attacks, and detoxifying medication overuse if present. Multidisciplinary integrated care that includes medical staff from different disciplines (e.g., psychiatry, clinical psychology, and physical therapy) has been recommended. The outcomes of inpatient treatment are satisfactory in terms of decreasing headache intensity or frequency, withdrawal from medication overuse, reducing disability, and improving life quality, although long-term relapse is not uncommon. In conclusion, inpatient treatment may be useful for select patients with refractory CDH and should be incorporated in a holistic headache care program.

Entities:  

Keywords:  Chronic daily headache; Chronic migraine; Inpatient; Medication overuse

Mesh:

Year:  2016        PMID: 26707496     DOI: 10.1007/s11916-015-0531-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  82 in total

1.  Efficacy of multidisciplinary treatment in a tertiary referral headache centre.

Authors:  P Zeeberg; J Olesen; R Jensen
Journal:  Cephalalgia       Date:  2005-12       Impact factor: 6.292

2.  Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache.

Authors:  P Rossi; J V Faroni; G Nappi
Journal:  Eur J Neurol       Date:  2011-03       Impact factor: 6.089

3.  Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.

Authors:  J Jones; D Sklar; J Dougherty; W White
Journal:  JAMA       Date:  1989-02-24       Impact factor: 56.272

Review 4.  Risk factors of chronic daily headache or chronic migraine.

Authors:  Soo-Jin Cho; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2015-01

5.  Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design.

Authors:  Signe B Munksgaard; Lars Bendtsen; Rigmor H Jensen
Journal:  Cephalalgia       Date:  2012-06-29       Impact factor: 6.292

6.  A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study.

Authors:  C Tassorelli; R Jensen; M Allena; R De Icco; G Sances; Z Katsarava; M Lainez; Ja Leston; R Fadic; S Spadafora; M Pagani; G Nappi
Journal:  Cephalalgia       Date:  2014-02-20       Impact factor: 6.292

Review 7.  A narrative review on the management of medication overuse headache: the steep road from experience to evidence.

Authors:  Paolo Rossi; Rigmor Jensen; Giuseppe Nappi; Marta Allena
Journal:  J Headache Pain       Date:  2009-10-03       Impact factor: 7.277

8.  Intravenous magnesium as acute treatment for headaches: a pediatric case series.

Authors:  Emily Gertsch; Sheila Loharuka; Kristine Wolter-Warmerdam; Suhong Tong; Allison Kempe; Sita Kedia
Journal:  J Emerg Med       Date:  2013-10-29       Impact factor: 1.484

9.  Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse.

Authors:  D R Williams; R J Stark
Journal:  Cephalalgia       Date:  2003-12       Impact factor: 6.292

10.  Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.

Authors:  Paolo Martelletti; Zaza Katsarava; Christian Lampl; Delphine Magis; Lars Bendtsen; Andrea Negro; Michael Bjørn Russell; Dimos-Dimitrios D Mitsikostas; Rigmor Højland Jensen
Journal:  J Headache Pain       Date:  2014-08-28       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.